401 related articles for article (PubMed ID: 30075979)
1. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
3. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
5. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
[TBL] [Abstract][Full Text] [Related]
6. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
7. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
van Ham NCM; Glazemakers S; van der Ende-van Loon M; Nieuwenhuijzen GAP; Rutten HJT; Tolenaar JL; Jacobs A; Burger JWA; Ketelaers SHJ; Bloemen JG
Eur J Surg Oncol; 2024 Jun; 50(6):108259. PubMed ID: 38552415
[TBL] [Abstract][Full Text] [Related]
9. [Surgical outcomes for 187 patients with locally recurrent rectal cancer and analysis of prognostic factors].
Jiang Y; Wan YL; Liu YC; Wang X; Pan YS; Wu T; Wang PY; Huang SJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):582-5. PubMed ID: 21866446
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
Hagemans JAW; Voogt ELK; Rothbarth J; Nieuwenhuijzen GAP; Kirkels WJ; Boormans JL; Koldewijn EL; Richardson R; Verhoef C; Rutten HJT; Burger JWA
Eur J Surg Oncol; 2020 Jun; 46(6):1160-1166. PubMed ID: 32122756
[TBL] [Abstract][Full Text] [Related]
11. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
12. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
13. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
[TBL] [Abstract][Full Text] [Related]
14. Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer.
Bosman SJ; Vermeer TA; Dudink RL; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
Eur J Surg Oncol; 2014 Jun; 40(6):699-705. PubMed ID: 24679359
[TBL] [Abstract][Full Text] [Related]
15. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
17. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
18. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
19. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]